Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nasdaq Biotechnology Ishares ETF (IBB)

Nasdaq Biotechnology Ishares ETF (IBB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 6,809,420,000
  • Shares Outstanding, K 50,500
  • 60-Month Beta 0.84
  • Price/Earnings ttm 15.68
  • Annual Dividend & Yield 0.45 (0.33%)
  • Most Recent Dividend 0.200 on 09/25/24
  • Management Fee 0.44%
  • Sectors:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 21.42% ( +0.08%)
  • Historical Volatility 21.44%
  • IV Percentile 92%
  • IV Rank 35.60%
  • IV High 33.78% on 08/05/24
  • IV Low 14.59% on 07/10/24
  • Put/Call Vol Ratio 0.10
  • Today's Volume 6,602
  • Volume Avg (30-Day) 7,038
  • Put/Call OI Ratio 1.64
  • Today's Open Interest 154,860
  • Open Int (30-Day) 140,567

Price Performance

See More
Period Period Low Period High Performance
1-Month
131.56 +2.49%
on 11/19/24
150.04 -10.13%
on 11/11/24
-11.07 (-7.59%)
since 10/18/24
3-Month
131.56 +2.49%
on 11/19/24
150.57 -10.44%
on 09/19/24
-12.54 (-8.51%)
since 08/20/24
52-Week
117.28 +14.97%
on 11/28/23
150.57 -10.44%
on 09/19/24
+15.92 (+13.39%)
since 11/20/23

Most Recent Stories

More News
5 Stocks Retail Investors Are Most Bullish On At Mid-Day

Retailers went overboard about a couple of biotech stocks and a MedTech name, among others on Wednesday.

FBRX : 13.55 (+128.69%)
QSI : 1.3900 (+119.59%)
DUOT : 5.20 (+13.04%)
IBB : 134.84 (+1.09%)
SLXN : 0.3331 (+47.26%)
SPY : 590.50 (+0.03%)
XBI : 94.01 (+0.90%)
ZIM : 27.01 (+0.86%)
Trump Names Anti-Vaxxer Robert Kennedy As Health & Human Services Secretary: Here’s What It Means For Healthcare Stocks

Trump said his HHS Secretary nominee will ensure the public is protected from harmful substances that have aggravated the nation’s health crisis.

NVO : 105.27 (+2.57%)
IBB : 134.84 (+1.09%)
LLY : 753.41 (+3.25%)
MRNA : 36.94 (-0.94%)
AMGN : 287.87 (+2.83%)
XBI : 94.01 (+0.90%)
PFE : 24.94 (-0.64%)
BNTX : 102.14 (-4.00%)
SNY : 47.78 (-0.46%)
Will Trump 2.0 Nurse Biotechs Back To Health: 10 Stocks Retail Is Watching

Less stringent requirements in pharmaceuticals and biotechnology could help biotechs by prompting accelerated drug approvals.

SRNE : 0.0033 (unch)
TNXP : 0.1900 (+16.78%)
IBB : 134.84 (+1.09%)
JAGX : 0.9799 (+1.07%)
NVAX : 8.06 (+0.75%)
INO : 3.97 (-1.49%)
GILD : 88.63 (+1.00%)
MRNA : 36.94 (-0.94%)
VXRT : 0.6078 (-1.97%)
IBIO : 2.19 (-1.79%)
XBI : 94.01 (+0.90%)
PFE : 24.94 (-0.64%)
Altimmune Stock Jumps As Obesity Drug Candidate Clears Key FDA Meeting: Retail Bulls Charge In

Altimmune said its obesity drug candidate is highly differentiated from other incretin-based agents currently available and in development.

IBB : 134.84 (+1.09%)
ALT : 8.05 (+7.76%)
XBI : 94.01 (+0.90%)
Moderna Stuns Wall Street With Surprise Profit On Strong US Vaccine Sales, Cost Tightening

Moderna attributed its strong third-quarter top-line growth to higher U.S. sales due to the earlier launch of the updated COVID-19 vaccine

IBB : 134.84 (+1.09%)
MRNA : 36.94 (-0.94%)
SPY : 590.50 (+0.03%)
XBI : 94.01 (+0.90%)
Moderna Stock Slips On Report Of CEO Relinquishing Sales Chief Role: Retail Mood Dims

Moderna's COVID-19 vaccine windfall is now a thing of the past as it struggles to shore up revenue and reverse to a profit.

IBB : 134.84 (+1.09%)
MRNA : 36.94 (-0.94%)
SPY : 590.50 (+0.03%)
XBI : 94.01 (+0.90%)
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now

The Federal Reserve's recent 50bps rate cut could significantly boost biotech companies by lowering borrowing costs and improving access to capital.

IBB : 134.84 (+1.09%)
GILD : 88.63 (+1.00%)
XBI : 94.01 (+0.90%)
Why Biotech ETFs Are Beating the Market

Biotech stocks have been outperforming the broader market over the past three months, driven by optimism regarding potential rate cuts. The Fed is expected to start cutting rates later this month, and...

REGN : 743.35 (-0.17%)
GILD : 88.63 (+1.00%)
IBB : 134.84 (+1.09%)
XBI : 94.01 (+0.90%)
SBIO : 37.16 (+0.73%)
Regeneron Pharmaceuticals Stock Outlook: Is Wall Street Bullish or Bearish?

Regeneron Pharmaceuticals has outperformed the broader market over the past year, and Wall Street analysts remain bullish on the stock’s prospects.

REGN : 743.35 (-0.17%)
$SPX : 5,917.11 (unch)
$SPX : 5,917.11 (unch)
IBB : 134.84 (+1.09%)
IBB : 134.84 (+1.09%)
3 ETFs for Growth Investors to Buy and Hold for Decades

These exchange-traded funds can help you easily tap into some promising growth opportunities.

IVZ : 17.41 (+0.81%)
AAPL : 229.00 (+0.32%)
NVDA : 145.89 (-0.76%)
QQQ : 503.17 (-0.06%)
IBB : 134.84 (+1.09%)
IWF : 392.76 (-0.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Fund Summary

The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology...

See More

Key Turning Points

3rd Resistance Point 137.96
2nd Resistance Point 136.49
1st Resistance Point 135.67
Last Price 134.84
1st Support Level 133.38
2nd Support Level 131.91
3rd Support Level 131.09

See More

52-Week High 150.57
Fibonacci 61.8% 137.85
Last Price 134.84
Fibonacci 50% 133.92
Fibonacci 38.2% 129.99
52-Week Low 117.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar